domingo, 31 de diciembre de 2023
sábado, 30 de diciembre de 2023
Thanks to readers from all over the world
Thank you to everyone who reads me, silently...
thanks to everyone who follows me every day...
thanks to all countries...
Estados Unidos
Suecia
Alemania
Singapur
Reino Unido
Corea del Sur
Irán
Francia
Hong Kong
Camboya
Canadá
Finlandia
España
Australia
Colombia
Afganistán
Irlanda
Rusia
China
Otros
New on NCI’s Websites for December 2023
https://www.cancer.gov/news-events/cancer-currents-blog/2023/new-online-december-2023?cid=eb_govdel
W. Kimryn Rathmell Begins Work as 17th Director of the National Cancer Institute
viernes, 29 de diciembre de 2023
BLUE LIGHT EXPOSURE: UNVEILING THE EFFECTS
Blue Light Exposure: Unveiling the Effects
By Ivanhoe Broadcast News on January 7, 2024
https://www.ivanhoe.com/?p=32112&preview=1&_ppp=95e6681095
ALEXANDRA’S ART FUNDS RESEARCH
Alexandra’s Art Funds Research
By Ivanhoe Broadcast News on January 7, 2024
https://www.ivanhoe.com/?p=32109&preview=1&_ppp=c4e13945ce
SENIORS BATTLING ANXIETY IN SILENCE
Seniors Battling Anxiety in Silence
By Ivanhoe Broadcast News on January 6, 2024
https://www.ivanhoe.com/?p=32106&preview=1&_ppp=516305e615
CHRONIC PAIN, INFLAMMATION AND DEMENTIA LINK
Chronic Pain, Inflammation and Dementia Link
By Ivanhoe Broadcast News on January 6, 2024
https://www.ivanhoe.com/?p=32103&preview=1&_ppp=23b67735d7
HEALING TOOTHPASTE: HYDROXYAPATITE TO THE RESCUE
Healing Toothpaste: Hydroxyapatite to The Rescue
By Ivanhoe Broadcast News on January 5, 2024
https://www.ivanhoe.com/?p=32100&preview=1&_ppp=405ac54d8f
NEW KIND OF CLASSROOM FOR SICK KIDS
New Kind of Classroom for Sick Kids
By Ivanhoe Broadcast News on January 4, 2024
https://www.ivanhoe.com/?p=32097&preview=1&_ppp=1c485ef109
PLAN B FOR STATIN-INTOLERANT PATIENTS
Plan B for Statin-Intolerant Patients
By Ivanhoe Broadcast News on January 3, 2024
https://www.ivanhoe.com/?p=32094&preview=1&_ppp=6e596c48d7
ARE NAPS REALLY BENEFICIAL?
Are Naps Really Beneficial?
By Ivanhoe Broadcast News on January 2, 2024
https://www.ivanhoe.com/?p=32091&preview=1&_ppp=a6fbedc497
HOSPITAL TO HOME: NURSES HELP NAVIGATE THEIR PATIENTS’ RECOVERY
Hospital to Home: Nurses Help Navigate Their Patients’ Recovery
By Ivanhoe Broadcast News on January 1, 2024
https://www.ivanhoe.com/?p=32088&preview=1&_ppp=84a1f596bc
Know the Science: Complementary and Integrative Health Resources From NCCIH
https://www.nccih.nih.gov/health/know-science?nav=govd
Complementary and Integrative Health Resources From NCCIH
https://www.nccih.nih.gov/health/atoz?nav=govd
Herbs at a Glance
https://www.nccih.nih.gov/health/herbsataglance?nav=govd
Alerts and Advisories
https://www.nccih.nih.gov/news/alerts?nav=govd
Connect With Us: Email Updates and Social Media
https://www.nccih.nih.gov/news/subscribe?nav=govd
jueves, 28 de diciembre de 2023
Don’t call me “old”: Avoiding ageism when writing about aging
https://www.nia.nih.gov/research/blog/2023/12/dont-call-me-old-avoiding-ageism-when-writing-about-aging?utm_source=NIA+Main&utm_campaign=0405749933-blog-ageist-language-12-27&utm_medium=email&utm_term=0_-8180ce9847-%5BLIST_EMAIL_ID%5D
Ageist messages are everywhere — you need only to browse a greeting card aisle to see countless quips about being a “geezer” or “over the hill.” Ageist content is so prevalent in our society that too many people may not recognize it as problematic.
Well-intentioned writers can sometimes inadvertently reinforce harmful stereotypes about older adults. Whether you’re writing a blog post, grant application, or journal article, here are some tips and resources to help your audience think more positively about aging.
In Mouse Study, KRAS-Targeted Drug Shows Potential against Pancreatic Cancer
https://www.cancer.gov/news-events/cancer-currents-blog/2023/pancreatic-cancer-kras-g12d-mrtx1133?cid=eb_govdel
Progress continues in targeting a hard-to-hit cancer protein
KRAS has been one of the most hard-to-hit targets in cancer research. But over the past 2 years, two new drugs, sotorasib (Lumakras) and adagrasib (Krazati), have been approved to treat people with non-small cell lung cancer that has the KRAS G12C mutation. This mutation occurs less frequently in other cancers and is only seen in about 1%–2% of pancreatic cancers. Even so, researchers have begun testing both drugs in small clinical trials of people with other cancers with KRAS G12C mutations.
In a trial involving 38 patients with advanced pancreatic cancer, for example, sotorasib shrank tumors in about 20% of participants. Similar results were seen with adagrasib in a trial involving people with advanced colorectal cancer.v
miércoles, 27 de diciembre de 2023
martes, 26 de diciembre de 2023
TOPS FUSION ALTERNATIVE
TOPS Fusion Alternative
By Ivanhoe Broadcast News on December 25, 2023
https://www.ivanhoe.com/medical-breakthroughs/tops-fusion-alternative/
GENE THERAPY: REDEFINING HEMOPHILIA TREATMENT
Gene Therapy: Redefining Hemophilia Treatment
By Ivanhoe Broadcast News on December 26, 2023
https://www.ivanhoe.com/medical-breakthroughs/gene-therapy-redefining-hemophilia-treatment/
THE HAMR FIGHTS CANCER
The HAMR Fights Cancer
By Ivanhoe Broadcast News on December 27, 2023
https://www.ivanhoe.com/?p=32066&preview=1&_ppp=c21391aa54
ACCUCINCH HEALS HEARTS
AccuCinch Heals Hearts
By Ivanhoe Broadcast News on December 28, 2023
https://www.ivanhoe.com/?p=32069&preview=1&_ppp=08e3153b5f
TOXIC VACATIONS: POISONED BY CARBON MONOXIDE
Toxic Vacations: Poisoned by Carbon Monoxide
By Ivanhoe Broadcast News on December 29, 2023
https://www.ivanhoe.com/?p=32072&preview=1&_ppp=6500216f10
THE MORNING AFTER: HANGOVER CURES THAT WORK
The Morning After: Hangover Cures That Work
By Ivanhoe Broadcast News on December 31, 2023
https://www.ivanhoe.com/?p=32053&preview=1&_ppp=02ab77cc75
FRESH START: EATING YOUR WAY TO BETTER HEALTH IN 2024
Fresh Start: Eating Your Way to Better Health In 2024
By Ivanhoe Broadcast News on December 30, 2023
https://www.ivanhoe.com/?p=32050&preview=1&_ppp=4fc6325863
OFFICE TIME-SUCKS: HOW TO OVERCOME PRODUCTIVITY PITFALLS
Office Time-Sucks: How to Overcome Productivity Pitfalls
By Ivanhoe Broadcast News on December 30, 2023
https://www.ivanhoe.com/?p=32047&preview=1&_ppp=01a96d92a9
Orphanet Journal of Rare Diseases: Experience of life quality from patients with aplastic anemia: a descriptive qualitative study
https://ojrd.biomedcentral.com/articles/10.1186/s13023-023-02993-y
The official journal of Orphanet, the portal for rare diseases and orphan drugs.
https://ojrd.biomedcentral.com/
LSU Health discovery may open new therapeutic avenues for degenerative diseases of the brain and eye
lunes, 25 de diciembre de 2023
domingo, 24 de diciembre de 2023
The infant gut virome is associated with preschool asthma risk independently of bacteria CL Rodriguez et al, Nature Medicine, December 15, 2023
https://phgkb.cdc.gov/PHGKB/phgHome.action?action=archive&date=12/15/2023
From the abstract: "Here, we analyze the gut virome of 647 children aged 1?year from the Copenhagen Prospective Studies on Asthma in Childhood2010 (COPSAC2010) mother–child cohort, all deeply phenotyped from birth and with longitudinally assessed asthma diagnoses. Specific temperate gut phage taxa were found to be associated with later development of asthma. In particular, the joint abundances of 19 caudoviral families were found to significantly contribute to this association. Combining the asthma-associated virome and bacteriome signatures had additive effects on asthma risk."
How Family History Influences Your Drinking DG Smith, NY Times, December 13, 2023
https://phgkb.cdc.gov/PHGKB/phgHome.action?action=archive&date=12/17/2023
From the article: " Alcohol use disorder — the inability to stop or control one’s drinking despite negative consequences — is a highly heritable condition. Research suggests that having an immediate family member, like a parent or sibling, with the disorder increases an individual’s chances of developing it roughly three- to fourfold. Approximately 50 percent of a person’s risk comes from their genes, but their home and social environments are also important factors."
Direct to Consumer Biomarker Testing for Alzheimer Disease—Are We Ready for the Insurance Consequences? JJ Arias et al, JAMA Neurology, December 18, 2023
https://phgkb.cdc.gov/PHGKB/phgHome.action?action=archive&date=12/18/2023
From the article: "The promise of DTC testing for AD biomarkers may be lauded by advocates pushing for earlier diagnoses and individuals’ right to know. Early diagnosis of AD through DTC or clinical evaluations could provide benefits, including increased monitoring and preventive care. Additionally, DTC tests could reduce barriers that impede a timely diagnosis (eg, access to dementia specialists). However, DTC tests are not without hazard, particularly given gaps in discriminatory protections for individuals at risk of developing AD with known biomarker status. "
Systematic review and meta-analysis of AI-based conversational agents for promoting mental health and well-being H Li, NPJ Digital Medicine, December 19, 2023
https://phgkb.cdc.gov/PHGKB/phgHome.action?action=archive&date=12/20/2023
From the abstract: "Conversational artificial intelligence (AI), particularly AI-based conversational agents (CAs), is gaining traction in mental health care. Despite their growing usage, there is a scarcity of comprehensive evaluations of their impact on mental health and well-being. This systematic review and meta-analysis aims to fill this gap by synthesizing evidence on the effectiveness of AI-based CAs in improving mental health and factors influencing their effectiveness and user experience. "
Using genomics to track malaria in the US T Locke, MedicalXpress, December 20, 2023
https://phgkb.cdc.gov/PHGKB/phgHome.action?action=all%20hot%20topics
From the website: "Both the parasite genome and the mosquito genome are very important because each of those represents a unique fingerprint. You can characterize the disease that's caused by that particular parasite and also track the parasites and the mosquitoes. Malaria parasites, for example, in parts of Ethiopia or India are different from each other, but those malaria parasites in India are similar to each other. If you don't know the origin of a malaria parasite, you can track it back to where it might have come from by comparing it with lots of different genomes of malaria parasites throughout the endemic world. "
sábado, 23 de diciembre de 2023
viernes, 22 de diciembre de 2023
jueves, 21 de diciembre de 2023
Phone-based Dementia Caregiver Education Program for Latino Families
https://www.alzheimers.gov/clinical-trials/phone-based-dementia-caregiver-education-program-latino-families?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231220
Start: May 1, 2022
End: Jan. 31, 2025
Enrollment: 100
Mobile Health Application To Reduce Caregiver Burden in Hispanic Dementia Caregivers
https://www.alzheimers.gov/clinical-trials/mobile-health-application-reduce-caregiver-burden-hispanic-dementia-caregivers?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231220
Start: Sept. 26, 2023
End: September 2025
Enrollment: 40
Emergency Preparedness Program for Dementia Caregivers
https://www.alzheimers.gov/clinical-trials/emergency-preparedness-program-dementia-caregivers?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231220
Start: July 12, 2023
End: June 30, 2027
Enrollment: 200
Interleukin-2 To Reduce Inflammation in Older Adults With Alzheimer's Disease
https://www.alzheimers.gov/clinical-trials/interleukin-2-reduce-inflammation-older-adults-alzheimers-disease?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231220
Start: Mar. 17, 2022
End: Dec. 30, 2025
Enrollment: 40
[11C]-CS1P1 PET Imaging To Detect Brain Inflammation in People With Dementia
https://www.alzheimers.gov/clinical-trials/11c-cs1p1-pet-imaging-detect-brain-inflammation-people-dementia?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231220
Start: May 5, 2023
End: May 2026
Enrollment: 80
Virtual Reality for Brain Health
https://www.alzheimers.gov/clinical-trials/virtual-reality-brain-health?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231220
Start: Aug. 8, 2023
End: Feb. 1, 2029
Enrollment: 150v
Mindful Walking Program To Slow Cognitive Decline in Older African Americans
https://www.alzheimers.gov/clinical-trials/mindful-walking-program-slow-cognitive-decline-older-african-americans?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20231220
Start: May 16, 2023
End: Sept. 30, 2025
Enrollment: 114
miércoles, 20 de diciembre de 2023
martes, 19 de diciembre de 2023
lunes, 18 de diciembre de 2023
Trends in migraine incidence among women of childbearing age from 1990 to 2019 and the prediction for 2030: an analysis of national data in China
REVOLUTIONARY EYELID PACEMAKER ENABLES BLINKING Hundreds of thousands of people suffer from facial paralysis each year, and until now there was no solution for the inability to blink.
REVOLUTIONARY EYELID PACEMAKER ENABLES BLINKING
Hundreds of thousands of people suffer from facial paralysis each year, and until now there was no solution for the inability to blink.
https://www.israel21c.org/revolutionary-eyelid-pacemaker-enables-blinking/
domingo, 17 de diciembre de 2023
sábado, 16 de diciembre de 2023
Story of discovery: NEI-funded research paves way for new dry AMD drugs FDA approves first drugs to treat the dry form of age-related macular degenerationStory of discovery: NEI-funded research paves way for new dry AMD drugs FDA approves first drugs to treat the dry form of age-related macular degeneration
DAMN DINKS! PLAYING PICKLEBALL PAIN-FREE
Damn Dinks! Playing Pickleball Pain-Free
By Ivanhoe Broadcast News on December 24, 2023
https://www.ivanhoe.com/?p=32007&preview=1&_ppp=9edda0a776
AI FRAUD ALERT: DON’T FALL FOR DEEPFAKES
AI Fraud Alert: Don’t Fall for Deepfakes
By Ivanhoe Broadcast News on December 23, 2023
https://www.ivanhoe.com/?p=32004&preview=1&_ppp=816b930419
PASS ON THE JOY: GIFTS THAT GIVE
Pass on The Joy: Gifts that Give
By Ivanhoe Broadcast News on December 23, 2023
https://www.ivanhoe.com/?p=32001&preview=1&_ppp=468ca79e08
BEATING LATE-STAGE CANCERS: TURNING CANCER CELLS AGAINST THEMSELVES
Beating Late-Stage Cancers
By Ivanhoe Broadcast News on December 22, 2023
https://www.ivanhoe.com/?p=32022&preview=1&_ppp=35a8df79fa
KETAMINE WORKS ON TREATMENT-RESISTANT DEPRESSION
Ketamine Works on Treatment-Resistant Depression
By Ivanhoe Broadcast News on December 21, 2023
https://www.ivanhoe.com/?p=32019&preview=1&_ppp=d02dc1703f
FIBROID FREEDOM: A HYSTERECTOMY-FREE SOLUTION
Fibroids Freedom: A Hysterectomy-Free Solution
By Ivanhoe Broadcast News on December 20, 2023
https://www.ivanhoe.com/?p=32016&preview=1&_ppp=b7c12a0064
PILL-LESS PAIN RELIEF: NEUROSTIMULATORS REPLACING OPIOIDS
Pill-less Pain Relief: Neurostimulators Replacing Opioids
By Ivanhoe Broadcast News on December 19, 2023
https://www.ivanhoe.com/?p=32013&preview=1&_ppp=de5e77e390
ROLLING AWAY BLOOD CLOTS
Rolling Away Blood Clots
By Ivanhoe Broadcast News on December 18, 2023
https://www.ivanhoe.com/?p=32010&preview=1&_ppp=5f8251fa5a
viernes, 15 de diciembre de 2023
jueves, 14 de diciembre de 2023
Berberine and Weight Loss: What You Need To Know
https://www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know?nav=govd
Berberine is a substance found in a variety of plants, including goldenseal, barberry, Oregon grape, and others. Plants containing berberine have a long history of use in both Ayurvedic and Chinese medicine. In modern times, plants containing berberine have been used for infections, skin diseases, digestive disorders, and other conditions. Berberine is currently being studied for its effects on diabetes and risk factors for heart disease. Recently, it has become popular as a potential weight loss aid.
Will variants of uncertain significance still exist in 2030?
https://pubmed.ncbi.nlm.nih.gov/38086381/
From the abstract: "In 2020, the National Human Genome Research Institute (NHGRI) made ten “bold predictions,” including that “the clinical relevance of all encountered genomic variants will be readily predictable, rendering the diagnostic designation ‘variant of uncertain significance (VUS)’ obsolete.” We discuss the prospects for this prediction, arguing that many, if not most, VUS in coding regions will be resolved by 2030. We outline a confluence of recent changes making this possible. "
Comprehensive assessment of the genetic characteristics of small for gestational age newborns in NICU: from diagnosis of genetic disorders to prediction of prognosis
https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-023-01268-2
From the abstract: "Among the 723 SGA newborns, 88(12.2%) received genetic diagnosis, including 42(47.7%) with monogenic diseases and 46(52.3%) with chromosomal abnormalities. SGA with genetic diagnosis showed higher rates in severe SGA(54.5% vs. 41.9%, P=0.0025) than SGA without genetic diagnosis. SGA with chromosomal abnormalities showed higher incidences of physical and neurodevelopmental delay compared to those with monogenic diseases (45.7% vs. 19.0%, P=0.012). "
'It's all gone': CAR-T therapy forces autoimmune diseases into remission
https://pubmed.ncbi.nlm.nih.gov/38087105/
From the article: "Engineered immune cells have given 15 people with once-debilitating autoimmune disorders a new lease on life, free from fresh symptoms or treatments. The results raise hopes that the approach — called CAR-T-cell therapy — might one day be extended to a variety of other conditions fuelled by rogue immune cells that produce antibodies against the body’s own tissues. "
Utility of smart watches for identifying arrhythmias in children
https://www.nature.com/articles/s43856-023-00392-9
From the abstract: " Arrhythmia symptoms are frequent complaints in children and often require a pediatric cardiology evaluation. Data regarding the clinical utility of wearable technologies are limited in children. We hypothesize that a smart watch can capture arrhythmias in children. We present an analysis of patients =18 years-of-age who had signs of an arrhythmia documented by a smart watch. We include patients evaluated at our center over a 4-year-period and highlight those receiving a formal arrhythmia diagnosis. We evaluate the role of the smart watch in arrhythmia diagnosis, the results of other ambulatory cardiac monitoring studies, and findings of any EP studies."
miércoles, 13 de diciembre de 2023
ON THE EDGE OF A BREAKTHROUGH: POSSIBLE SICKLE CELL SOLUTION
Possible Sickle Cell Solution
By Ivanhoe Broadcast News on November 14, 2023
https://www.ivanhoe.com/medical-breakthroughs/possible-sickle-cell-solution/
FUTURE OF CARDIAC CARE: LIFESAVING TECH PREVENTS SUDDEN CARDIAC DEATH
Lifesaving Tech Prevents Sudden Cardiac Arrest
By Ivanhoe Broadcast News on November 15, 2023
https://www.ivanhoe.com/medical-breakthroughs/future-of-cardiac-care-lifesaving-tech-prevents-sudden-cardiac-arrest/
WI-FI WOES: FACTORS THAT CRIPPLE YOUR CONNECTION
Wi-Fi Woes: Factors That Cripple Your Connection
By Ivanhoe Broadcast News on December 17, 2023
https://www.ivanhoe.com/?p=31958&preview=1&_ppp=9fe6b2be55
SAVOR THE SEASON: SOUL-SOOTHING FOODS TO BEAT THE WINTER BLUES
Soul-Soothing Foods to Beat the Winter Blues
By Ivanhoe Broadcast News on December 16, 2023
https://www.ivanhoe.com/?p=31955&preview=1&_ppp=9d5de66e20
HOW TO “SLEIGH” YOUR BUDGET & SAVE HUNDREDS THIS HOLIDAY
How to “Sleigh” Your Budget & Save Hundreds this Holiday
By Ivanhoe Broadcast News on December 16, 2023
https://www.ivanhoe.com/?p=31952&preview=1&_ppp=a204504fb0
AHEAD OF THE BIOLOGICAL CLOCK: EARLY MENOPAUSE TRIGGERS
Ahead of the Biological Clock: Early Menopause Triggers
By Ivanhoe Broadcast News on December 15, 2023
https://www.ivanhoe.com/?p=31949&preview=1&_ppp=125d406a79
KWANZAA: 7 ESSENTIAL FACTS TO ILLUMINATE THE CELEBRATION
Kwanzaa: 7 Essential Facts to Illuminate the Celebration
By Ivanhoe Broadcast News on December 14, 2023
https://www.ivanhoe.com/?p=31946&preview=1&_ppp=fea57118e6
AI SUPER CHARGES MRI
AI Super Charges MRI
By Ivanhoe Broadcast News on December 13, 2023
https://www.ivanhoe.com/medical-breakthroughs/ai-super-charges-mri/
TESLA TARGETS EPILEPSY
Epilepsy: Tesla Targets
By Ivanhoe Broadcast News on December 12, 2023
https://www.ivanhoe.com/family-health/children/epilepsy-tesla-targets/
A PREMIER WAY TO TREAT ESOPHAGEAL CANCER
Esophageal Cancer: A Premier Way to Treat
By Ivanhoe Broadcast News on December 11, 2023
https://www.ivanhoe.com/medical-breakthroughs/esophageal-cancer-a-premier-way-to-treat/
martes, 12 de diciembre de 2023
Suscribirse a:
Entradas (Atom)